Cx36 haplotype frequency in JME cases and controls
| Haplotype* | 15q14 JME†, n (%) | RS JME, n (%) | Combined, n (%) | Control, n (%) |
|---|---|---|---|---|
| *Haplotype inferred using PHASE for the four SNPs 333, 369, 588, and 888, respectively; p = 0.02 (p value computed using Fisher’s exact test, gives the significance value of the comparison of haplotype frequencies between JME and control cases). | ||||
| ACCG | 13 (22.4) | 81 (28.9) | 94 (27.8) | 81 (32.9) |
| TCCG | 18 (31.1) | 82 (29.3) | 100 (29.6) | 79 (32.2) |
| TCTG | 16 (27.6) | 65 (23.2) | 81 (24) | 41 (16.7) |
| TCTA | 7 (12.1) | 32 (11.4) | 39 (11.5) | 28 (11.4) |
| TTCG | 1 (1.7) | 20 (7.2) | 21 (6.2) | 16 (6.5) |
| ACTG | 1 (1.7) | 0 | 1 (0.3) | 1 (0.3) |
| TTCA | 1 (1.7) | 0 | 1 (0.3) | 0 |
| TCCA | 1 (1.7) | 0 | 1 (0.3) | 0 |